Business
Notice of Lattice Biologics Ltd. First Quarter 2017 Financial Results Conference Call
Notice of Lattice Biologics Ltd. First Quarter 2017 Financial Results Conference Call.
About this update from Lattice Biologics Ltd
[{"type":"text","content":"\nNotice of Lattice Biologics Ltd. First Quarter 2017 Financial Results Conference Call\n\nNotice of Lattice Biologics Ltd. First Quarter 2017 Financial Results Conference Call\n\n\nFinancial results to be released after market on Wednesday, March 1, 2017\n\nSCOTTSDALE, AZ --(Marketwired - February 14, 2017) - Lattice Biologics Ltd. (TSX VENTURE: LBL) (OTCQB: LBLTF) (the \"Company\") announced today that it will release its first quarter 2017 financial results after market on Wednesday, March 1, 2017. Following this, Guy Cook, Chief Executive Officer, and Cheryl Farmer, Chief Financial Officer, will host a conference call at 6:30 a.m. PDT on Thursday, March 2, 2017 to review the results. A question and answer session will follow the corporate update.CONFERENCE CALL DETAILS:DATE:Thursday, March 2, 2017TIME:6:30 AM Pacific TimeDIAL-IN NUMBER:(213) 416-1560ATTENDEE PIN:286 6963#Register for the online webinar for full meeting functionality:http://www.anymeeting.com/LatticeBiologicsA recording of the call will be archived on the Company's website at:http://www.latticebiologics.com/webinars/Lattice Biologics Ltd.Guy Cook, Chief Executive OfficerTelephone No: (480) 563-0800About Lattice Biologics Ltd.:Lattice Biologics Ltd. is an emerging precision medicine leader in the field of cellular therapies and tissue engineering, with an emphasis on bone, skin, and cartilage regeneration. As a manufacturer of the highest quality allografts, Lattice is focused on next generation products to improve surgical outcomes.Versatile allografts for a variety of surgical applications:Enhancing fusion in spine surgeryEnhancing breast reconstruction post mastectomy for breast cancer patientsSports medicine indications, including ACL repairPromotion of bone regeneration in foot and ankle surgeryPromotion of cranial healing following neurosurgeryEnhancing wound repair in burn victimsSubchondral bone defect repair in knee and other joint surgeriesThe Company is currently exploring new technologies in regenerative and personalized medicine: All natural amniotic fluid supplement for arthritic joints Demonstrates lasting pain relief and improved outcomes Personalized Cancer Diagnostics - revolutionary high-throughput precision chemotherapy screening See study details Lattice Biologics operates headquarters, laboratory and manufacturing facilities in Scottsdale...